Iluzanebart (VGL101), Vigil’s monoclonal antibody program, is not being acquired by Sanofi, and its return to Amgen, the original licensor, and the termination of the exclusive license agreement with ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, presented 11 ...

Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Higher intake of methyl adaptogen foods, such as turmeric, green tea, and berries, was associated with reduced epigenetic age ...

As if we haven’t been collectively subjected to enough depressing news lately, scientists have found more evidence that ...

Biotechnology has become the backbone of data-driven healthcare. With this advancement comes significant ethical and security ...